脑池造瘘联合脑池引流对动脉瘤性蛛网膜下腔出血后迟发性脑积水的积极影响
该回顾性研究纳入2009年1月至2021年9月间89例接受手术或血管内治疗的动脉瘤性蛛网膜下腔出血患者,比较外部脑室引流与脑池引流对脑室-腹腔分流率的影响。脑池造瘘联合脑池引流组的分流率显著低于外部脑室引流组(9.09% vs 53.78%,p<0.001),手术夹闭亚组分析结果一致(9.5% vs 43.7%,p=0.02)。作者认为脑池造瘘联合脑池引流可能降低分流依赖性脑积水发生率。
要点
- 脑池造瘘联合脑池引流组脑室-腹腔分流率为9.09%,外部脑室引流组为53.78%(p<0.001)。
- 手术夹闭亚组中,脑池引流组分流率9.5%,外部脑室引流组43.7%(p=0.02)。
- 两组流行病学特征、WFNS评分、Fisher分级、脑室内出血、急性脑积水、术后脑膜炎及末次随访临床结局均无统计学显著差异。
核心结论
- 脑池造瘘联合脑池引流可能降低分流依赖性脑积水的发生率。
- 脑池造瘘可清除蛛网膜下腔血液,从而减轻蛛网膜炎症和纤维化,脑池引流可能增强此效应,导致慢性脑积水发生率降低。
研究设计与样本
- 回顾性综述,纳入2009年1月至2021年9月间89例连续接受手术和血管内治疗的动脉瘤性蛛网膜下腔出血患者。
- 患者分为两组:第1组为外部脑室引流组,第2组为脑池引流组;另对仅接受手术治疗的患者进行亚组分析。
- 比较两组基线特征、临床结局和分流率。
主要发现
- 两组流行病学特征、WFNS评分、Fisher分级、脑室内出血存在情况、急性脑积水、术后脑膜炎或末次随访临床结局均无统计学显著差异。
- 脑池造瘘联合脑池引流(第2组)与外部脑室引流(第1组)相比,脑室-腹腔分流率显著降低(9.09% vs 53.78%;p<0.001)。
- 亚组分析中,手术夹闭患者的外部脑室引流组脑室-腹腔分流率为43.7%,脑池引流组为9.5%(p=0.02)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hydrocephalus is one of the major complications of aneurysmal subarachnoid haemorrhage (aSAH). In the acute setting, an external ventricular drain (EVD) is used for early management. A cisternal drain (CD) coupled with the micro-surgical opening of basal cisterns can be an alternative when the aneurysm is clipped. Chronic hydrocephalus after aSAH is managed with ventriculo-peritoneal (VP) shunt, a procedure associated with a wide range of complications. The aim of this study is to analyse the impact of micro-surgical opening of basal cisterns coupled with CD on the incidence of VP shunt, compared to patients treated with EVD. METHODS: The authors conducted a retrospective review of 89 consecutive cases of patients with aSAH treated surgically and endovascularly with either EVD or CD between January 2009 and September 2021. Patients were stratified into two groups: Group 1 included patients with EVD, Group 2 included patients with CD. Subgroup analysis with only patients treated surgically was also performed. We compared their baseline characteristics, clinical outcomes and shunting rates. RESULTS: There were no statistically significant differences between the two groups in terms of epidemiological characteristics, WFNS score, Fisher scale, presence of intraventricular hemorrhage (IVH), acute hydrocephalus, postoperative meningitis or of clinical outcomes at last follow-up. Cisternostomy with CD (Group 2) was associated with a statistically significant reduction in VP-shunt compared with the use of an EVD (Group 1) (9.09% vs 53.78%; p < 0.001). This finding was confirmed in our subgroup analysis, as among patients with a surgical clipping, the rate of VP shunt was 43.7% for the EVD group and 9.5% for the CD group (p = 0.02). CONCLUSIONS: Cisternostomy with CD may reduce the rate of shunt-dependent hydrocephalus. Cisternostomy allows the removal of subarachnoid blood, thereby reducing arachnoid inflammation and fibrosis. CD may enhance this effect, thus resulting in lower rates of chronic hydrocephalus.
引用
- Garvayo M, Messerer M, Starnoni D, et al. The positive impact of cisternostomy with cisternal drainage on delayed hydrocephalus after aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien). 2022. PMID: 36504078. doi:10.1007/s00701-022-05445-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。